Refine by
Small Molecule Drug Articles & Analysis
82 news found
The topics set for the 2025 edition would highlight small-molecule drug discovery, novel modalities, and translational technologies with a particular focus on targeting protein degradation, RNA therapeutics, and precision drug delivery systems, which are all areas where BOC Sciences has built extensive expertise for years. ...
In an era where technological advancements are constantly reshaping the landscape of the pharmaceutical industry, Protheragen-ING has emerged as a frontrunner with its cutting-edge AI-synthesizer for small molecule drug synthesis. This revolutionary platform is transforming traditional drug formulation processes by employing a ...
This iterative process facilitates the creation of drug candidates that not only show promise in early trials but are also more likely to advance through the rigorous drug development pipeline. ...
RDCs leverage medical radionuclides to integrate treatment modalities with diagnostic capabilities, augmenting personalized medicine efforts. Small Molecule Drug Conjugates (SMDCs) service is also a significant part of CD Formulation’s portfolio. Utilizing small molecules for targeting, rather than ...
Following with the announcement of developing small molecule drug for glaucoma, Ace Therapeutics recently unveiled disease model customization services to accelerate further the preclinical research on gastroenterology (GI) and hepatology. ...
At the same time, Alfa Cytology can also offer drug development services for pancreatic cancer with the data obtained from PC basic research. “The new drug development services focus on the hotspot of pancreatic tumor. We closely work with researchers to develop small molecule drugs and peptide ...
Small molecules play a crucial role in modern drug discovery and development. ...
These microneedles are composed of a biocompatible material that dissolves upon insertion, allowing for controlled and targeted drug release. The dissolving microneedle preparation services offered by CD Formulation provide a comprehensive solution for pharmaceutical companies looking to optimize drug delivery. ...
Customization for Personalized Medicine: Antibodies are tailored to individual patient profiles, enhancing the potential for personalized medicine and increasing treatment efficacy while minimizing side effects. 5. Integration with Protein Drug Design: CD ComputaBio's platform seamlessly integrates Antibody De Novo Design with Protein Drug Design, ...
This critical step in the drug development process refers to the systematic evaluation of the safety of therapeutic drugs through laboratory studies and animals in vitro. ...
In addition, Creative Diagnostics possesses a variety of ELISA kits for the detection of hundreds of different proteins and molecules, including cytokines, growth factors, markers of infectious diseases, diabetes and tumors, small molecular drugs, and more. ...
The company is pleased to announce the launch of the Protein-Small Molecule Docking service, designed to help customers quickly and accurately design and screen drugs. ...
Caroline Man Xu, Co-founder and CEO of ViGeneron said: “The evolution of medicines from small molecules to proteins has driven increased therapeutic benefits in the past; the next generation of gene therapies holds tremendous promise for patients. ...
Blockbuster potential is also attributed to elinzanetant, an innovative, non-hormonal small molecule being developed for the treatment of vasomotor symptoms during menopause. ...
ByBayer AG
About Proteros biostructures GmbH Proteros is a privately-held company with expertise in structure-based drug discovery powered by a cutting-edge discovery engine tailored to unlock even the most technically challenging disease-relevant drug targets. The company provides small molecule drug discovery services ...
PHILADELPHIA, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing novel treatments for breast and gynecologic cancers, announced preliminary Phase 2 data from the ongoing SMILE trial of onapristone extended release (ONA-XR), the company’s novel, first-in-class, potent, ...
As an industry leader in the field, CD Formulation’s one-stop drug formulation solutions cover the R&D of small molecule formulations, biologics, microecological formulations, etc. One-stop Solution for Small Molecule Drug Formulation Small molecules ...
Levinson, today announced a research collaboration to discover and develop small molecule therapeutics for diseases of aging, including cancer. Under the terms of the agreement, Terray and Calico will identify small molecule leads against a set of targets nominated by Calico using the Terray tNova platform, with Calico ...
NEW YORK, Oct. 12, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. In recent weeks, randomized, placebo-controlled clinical trials were initiated in ...
” “Despite decades of effort, many targets remain inaccessible to traditional small molecule drugs, and many others have uncertain relevance to disease,” said Vividion Therapeutics CEO Jeffrey Hatfield. ...
ByBayer AG